title: IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controls.
authors.affiliation: Department of Radiology, Universitaetsklinikum Rudolf-Virchow, Berlin, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Cordes
authors.forename: J
authors.initials: J
authors.lastname: Hierholzer
authors.forename: L
authors.initials: L
authors.lastname: Schelosky
authors.forename: W
authors.initials: W
authors.lastname: Poewe
authors.forename: I
authors.initials: I
authors.lastname: Cordes
authors.forename: R
authors.initials: R
authors.lastname: Horowski
authors.forename: H
authors.initials: H
authors.lastname: Eichstaedt
authors.forename: D
authors.initials: D
authors.lastname: Schmidt
authors.forename: R
authors.initials: R
authors.lastname: Felix
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001549:Benzamides / Q000493:pharmacokinetics*; D003342:Corpus Striatum / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000503:physiopathology; D065127:Dopamine D2 Receptor Antagonists; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000503:physiopathology; D011759:Pyrrolidines / Q000493:pharmacokinetics*; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D000978:Antiparkinson Agents; D001549:Benzamides; D065127:Dopamine D2 Receptor Antagonists; D011759:Pyrrolidines; D017448:Receptors, Dopamine D2; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide